Benefits
Chronic fatigue 8-week pilot RCT (Front Pharmacol 2021)
2021 randomized pilot trial in Frontiers in Pharmacology — 8-week supplementation IMPROVED FATIGUE SCORES in 60 adults with chronic fatigue syndrome (P<0.05). Foundational fatigue-specific human evidence supporting TCM 'qi-tonifying' indication. Adaptogen positioning.
Oncology adjuvant chemo trial (NCT05613465)
NCT05613465 — Zhejiang Provincial People's Hospital double-blind randomized controlled study of adjuvant chemotherapy + Codonopsis pilosula vs placebo after radical surgery for PANCREATIC CARCINOMA. Cancer-related fatigue endpoint. Codonopsis oral liquid form (approved listed Chinese product). Foundational integrative oncology evidence.
COPD herbal formulae meta-analysis
Singh 2015 (Phytotherapy Research 29:167-186) — systematic review + meta-analysis of Dang Shen-containing herbal formulae for chronic obstructive pulmonary disease (COPD). Multiple RCTs synthesized. Foundational COPD adjunct evidence — supports TCM 'lung qi tonifying' indication.
Antifatigue + antihypoxia polysaccharides (Xie 2020)
Xie Q et al. 2020 (Food Funct 11:6352-6362) — antifatigue + antihypoxia activities of OLIGOSACCHARIDES + POLYSACCHARIDES from C. pilosula in mice. Foundational mechanism evidence — polysaccharides + oligosaccharides as antifatigue actives. Mouse model — supports proposed adaptogen mechanism.
Gastric ulcer protective (Wang 1997)
Wang ZT et al. 1997 (Gen Pharmacol 28:469-473) — Codonopsis pilosula extract PROTECTIVE action on experimentally-induced gastric ulcer in rats. Foundational TCM 'spleen-tonifying' mechanism evidence. Cytoprotective gastric mucosa effects.
Active constituents: dangshenosides + polysaccharides
Active compounds: TANGSHENOSIDES (steroidal glycosides — particularly tangshenoside I structurally similar to ginsenosides), SYRINGIN (eleutheroside B — phenylpropanoid with immunomodulatory + antifatigue effects), POLYSACCHARIDES, ALKALOIDS (codonopsine), TRITERPENES, POLYACETYLENES, PHENOLIC ACIDS. Foundational phytochemistry.
HONEST: 'poor man's ginseng' less stimulating
HONEST framing: in Asian medicine called 'POOR MAN'S GINSENG' — has SIMILAR BENEFITS as Panax ginseng but LESS EXPENSIVE + LESS STIMULATING. Distinguishing positioning vs Panax — gentler adaptogen profile suitable for sensitive populations or extended use. Trade-off: lower potency vs better tolerability.
Mechanism of action
HPA axis modulation (saponins)
Saponins in C. pilosula interact with glucocorticoid receptors → HPA axis stress response modulation. Mechanism: foundational adaptogen mechanism.
Polysaccharide + oligosaccharide antifatigue
Xie 2020 — polysaccharides + oligosaccharides demonstrate antifatigue + antihypoxia activities in mice. Mechanism: cellular energy support + oxygen utilization.
Cytokine balance immunomodulation
Dangshen polysaccharides boost cytokine balance — helps adapt to physical or metabolic stress. Mechanism: immune homeostasis + stress adaptation.
Gastric mucosa cytoprotection
Wang 1997 — protective action on gastric ulcer in rats. Mechanism: cytoprotective effects on gastric mucosa supporting TCM 'spleen-tonifying' indication.
Phenolic anti-inflammatory + antioxidant
Phenolic acids confer mild anti-inflammatory + antioxidant effects + protect cellular membranes from lipid peroxidation. TCM 'cooling yet strengthening' quality.
Codonopsine vasodilation (animal models)
Codonopsine (alkaloid) may exert mild hypotensive effects via vasodilation per animal models. Mechanism: cardiovascular support — supplementary to primary adaptogen activity.
Clinical trials
Randomized pilot trial published in Frontiers in Pharmacology 2021.
60 adults with chronic fatigue syndrome. C. pilosula supplementation × 8 weeks vs placebo. Fatigue scores assessment.
Supplementation IMPROVED FATIGUE SCORES in chronic fatigue syndrome adults (P<0.05). Foundational fatigue-specific human evidence supporting TCM 'qi-tonifying' indication. Positioning as adaptogenic herb for adrenal fatigue / burnout symptoms.
Randomized double-blind controlled trial (Zhejiang Provincial People's Hospital).
Pancreatic carcinoma patients post radical surgery on adjuvant chemotherapy (gemcitabine + albumin-paclitaxel per NCCN guidelines first-line). Codonopsis pilosula Nannf oral liquid (approved listed Chinese product) vs placebo.
Foundational integrative oncology RCT — cancer-related fatigue endpoint with TCM herbal adjunct. Status: UNKNOWN (per registry). Important integrative oncology research base supporting cancer-related fatigue + chemotherapy support indication.
Systematic review + meta-analysis (Singh B et al. 2015, Phytotherapy Research 29:167-186).
Multiple RCTs of Dang Shen-containing herbal formulae for chronic obstructive pulmonary disease (COPD).
Foundational COPD adjunct evidence — supports TCM 'lung qi tonifying' indication. Multiple RCTs synthesized. Important respiratory health application — distinguishes from generic adaptogen positioning. Combination context — Dang Shen typically used in formulas not isolated.
About this ingredient
CODONOPSIS PILOSULA (Franch.) Nannf. is a TRADITIONAL CHINESE MEDICINAL HERB called DANG SHEN ('Party Ginseng') or 'POOR MAN'S GINSENG' — Codonaceae family (formerly Campanulaceae). >60 species in genus. Used >2000 years in TCM as GENTLER TONIC ALTERNATIVE to Panax ginseng. TCM indications: TONIFY SPLEEN + LUNG QI, dyspnea, cough, asthma, bronchitis, poor immune function, stress, fatigue, adrenal fatigue, chemotherapy/radiation side-effects. Ingredient in classical 'CHANGE OF SEASON SOUP'. Active compounds: TANGSHENOSIDES (steroidal glycosides — tangshenoside I structurally similar to ginsenosides), SYRINGIN (eleutheroside B — phenylpropanoid with immunomodulatory + antifatigue effects), POLYSACCHARIDES, CODONOPSINE (alkaloid), TRITERPENES, POLYACETYLENES, PHENOLIC ACIDS. PIVOTAL CLINICAL EVIDENCE: 2021 FRONTIERS IN PHARMACOLOGY pilot RCT — 8-week supplementation IMPROVED FATIGUE SCORES in 60 adults with chronic fatigue syndrome (P<0.05). NCT05613465 ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL double-blind RCT — adjuvant chemotherapy + Codonopsis pilosula Nannf oral liquid (approved listed Chinese product) vs placebo for pancreatic carcinoma post radical surgery (gemcitabine + albumin-paclitaxel first-line per NCCN). SINGH B et al. 2015 (Phytother Res 29:167-186) COPD herbal formulae systematic review + meta-analysis. XIE Q et al. 2020 (Food Funct 11:6352-6362) — antifatigue + antihypoxia activities of polysaccharides + oligosaccharides in mice. WANG ZT et al. 1997 (Gen Pharmacol 28:469-473) — gastric ulcer protective in rats. WANG J et al. 2021 — herbal extract enhances CARDIOGENIC DIFFERENTIATION + improves function of infarcted rat hearts. SINGH 2004 — Dangshen + Bai guo (Ginkgo biloba) enhance learning + memory.
MECHANISMS: HPA AXIS modulation (saponins → glucocorticoid receptor); POLYSACCHARIDE + OLIGOSACCHARIDE antifatigue (Xie 2020); CYTOKINE BALANCE immunomodulation; GASTRIC MUCOSA CYTOPROTECTION (Wang 1997 'spleen-tonifying'); PHENOLIC ANTI-INFLAMMATORY + ANTIOXIDANT; CODONOPSINE VASODILATION mild hypotensive (animal models). EVIDENCE: 3/5 reflects: (1) 2021 Front Pharmacol 60-pt chronic fatigue pilot RCT, (2) NCT05613465 pancreatic carcinoma adjuvant chemo double-blind RCT, (3) SINGH 2015 COPD systematic review + meta-analysis, (4) XIE 2020 antifatigue + antihypoxia mechanism evidence, (5) WANG 1997 gastric ulcer protective mechanism, (6) >2000 YEAR TCM use record (Shennong Bencao Jing era), (7) DISTINGUISHING 'poor man's ginseng' positioning — gentler than Panax, (8) MULTI-SYSTEM applications (energy, immune, respiratory, GI, integrative oncology), (9) HONEST FRAMING — most evidence in TCM combination formulas + small clinical trials, (10) DEDICATED CHINESE clinical research base distinguishes from typical TCM herb. SAFETY: Excellent — >2000 year TCM record + extensive culinary/medicinal use. Best positioned as: (a) GENTLE ADAPTOGEN for chronic fatigue + adrenal fatigue (2021 Front Pharmacol RCT), (b) INTEGRATIVE ONCOLOGY adjunct (NCT05613465 pancreatic + chemotherapy support), (c) RESPIRATORY HEALTH support — COPD adjunct (Singh 2015 meta-analysis), (d) IMMUNE TONIC for stress + low immunity (TCM heritage + cytokine modulation), (e) DIGESTIVE/GASTRIC SUPPORT (Wang 1997 ulcer protection), (f) PANAX GINSENG ALTERNATIVE for those wanting gentler stimulation, (g) PREGNANCY: TCM record but limited Western data, (h) LESS STIMULATING profile distinguishes from Panax — better extended-use tolerability, (i) higher-evidence than typical TCM herb due to dedicated Chinese clinical research. Honest framing: Codonopsis pilosula (Dang Shen) is a foundational TCM 'spleen + lung qi tonifying' herb with emerging Western clinical evidence — 2021 Front Pharmacol 60-pt chronic fatigue pilot RCT + NCT05613465 pancreatic cancer adjunct + Singh 2015 COPD meta-analysis support multi-system applications. 'Poor man's ginseng' distinguishing positioning — similar benefits to Panax but less stimulating + less expensive. Tangshenoside I structural similarity to ginsenosides + syringin/eleutheroside B (shared with Eleutherococcus) supports adaptogen mechanism framework. Most clinical evidence in TCM COMBINATION FORMULAS (Change of Season Soup, Si Jun Zi Tang, etc.) rather than isolated. Reasonable gentle adaptogen for chronic fatigue + adrenal fatigue + integrative oncology + respiratory support — particularly compelling for those seeking Panax alternative or wanting Western-validated TCM adaptogen with multi-system application potential. Position as GENTLE TONIC + COMBINATION FORMULA component.